The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
European consensus statement on phenotypes of pustular psoriasis
Open accessAbstract
Pustular psoriasis (PP) is a group of inflammatory skin conditions characterized by infiltration of neutrophil granulocytes in the epidermis to such an extent that clinically visible sterile pustules develop. Because of clinical co‐incidence, PP is currently grouped with psoriasis vulgaris (PV). However, PP and PV are phenotypically different, respond differently to treatments and seem to be distinct on the genetic level. In contrast to PV, the phenotypes of PP are not well defined. Descriptions of each form of PP are discordant among standard dermatology textbooks [Saurat Dermatologie 2016, Rook's Dermatology 2016, Fitzpatrick's 2012 and Braun‐Falco 2012], encumbering the collection of phenotypically well‐matched groups of patients as well as clinical trials. The European Rare and Severe Psoriasis Expert Network (ERASPEN) was founded to define consensus criteria for diagnosis, deeply phenotype large groups of PP patients, analyse the genetics and pathophysiology and prepare for prospective clinical trials. This work reviews historical aspects of these conditions, new genetic findings and presents our initial considerations on the phenotypes of PP and a consensus classification of clinical phenotypes that will be used as a baseline for further, prospective studies of PP. Generalized pustular psoriasis (GPP) is defined as primary, sterile, macroscopically visible pustules on non‐acral skin (excluding cases where pustulation is restricted to psoriatic plaques). GPP can occur with or without systemic inflammation, with or without PV and can either be a relapsing (>1 episode) or persistent (>3 months) condition. Acrodermatitis continua of Hallopeau (ACH) is characterized by primary, persistent (>3 months), sterile, macroscopically visible pustules affecting the nail apparatus. Palmoplantar pustulosis (PPP) has primary, persistent (>3 months), sterile, macroscopically visible pustules on palms and/or soles and can occur with or without PV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, E., Cluzeau, C., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 998
Onoufriadis, A., Simpson, M. A., Pink, A. E., Di Meglio, P., Smith, C. H., Pullabhatla, V., Knight, J., Spain, S. L., Nestle, F. O., Burden, A. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.022 · Cited by 529
Self-citationRare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis
Jordan, C. T., Cao, L., Roberson, E. D. O., Duan, S., Helms, C. A., Nair, R. P., Duffin, K. C., Stuart, P. E., Goldgar, D., Hayashi, G., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.03.013 · Cited by 356
[Acute generalized exanthematic pustuloses (four cases) (author's transl)].
Beylot, C., Bioulac‐Sage, P., & Doutre, M. ‐. (1980) · PubMed · Cited by 195
Eosinophilic Pustular Folliculitis
(2017) · Diagnostic Pathology: Nonneoplastic Dermatopathology · doi:10.1016/b978-0-323-37713-3.50148-5 · Cited by 187
AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking
Setta-Kaffetzi, N., Simpson, M. A., Navarini, A. A., Patel, V. M., Lu, H.-C., Allen, M. H., Duckworth, M., Bachelez, H., Burden, A. D., Choon, S.-E., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.04.005 · Cited by 186
Self-citationDown's syndrome and acute leukemia: Myeloblastic or lymphoblastic?
Rosner, F., & Lee, S. L. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90130-1 · Cited by 180
Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes
Setta-Kaffetzi, N., Navarini, A. A., Patel, V. M., Pullabhatla, V., Pink, A. E., Choon, S.-E., Allen, M. A., Burden, A. D., Griffiths, C. E. M., Seyger, M. M. B., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.490 · Cited by 172
Self-citationIL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
Hussain, S., Berki, D. M., Choon, S. E., Irvine, A. D., Allen, M. H., Aróstegui, J. I., Chaves, A., Duckworth, M., Irvine, A. D., Mockenhaupt, M., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.043 · Cited by 146
Self-citationNavarini, A. A., Valeyrie‐Allanore, L., Setta-Kaffetzi, N., Barker, J. N., Capon, F., Creamer, D., Roujeau, J., Sekula, P., Simpson, M. A., Trembath, R. C., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.44 · Cited by 141
Self-citationSugiura, K. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.006 · Cited by 125
Berki, D. M., Liu, L., Choon, S. E., Burden, A. D., Griffiths, C. E. M., Navarini, A. A., Tan, E. S. T., Irvine, A. D., Ranki, A., Ogo, T., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.288 · Cited by 117
Self-citationBimodal immune activation in psoriasis
Christophers, E., Metzler, G., & Röcken, M. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12631 · Cited by 117
Mutations in IL36RN in Patients with Generalized Pustular Psoriasis
Körber, A., Mößner, R., Renner, R., Sticht, H., Wilsmann‐Theis, D., Schulz, P., Sticherling, M., Traupe, H., & Hüffmeier, U. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.214 · Cited by 104
Pustular Miliaria Rubra: A Specific Cutaneous Finding of Type I Pseudohypoaldosteronism
Urbatsch, A., & Paller, A. S. (2002) · Pediatric Dermatology · doi:10.1046/j.1525-1470.2002.00090.x · Cited by 48
Psoriasis and Related Disorders
Burden, A. D., & Kirby, B. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0036 · Cited by 47
Self-citation
Cited by
Psoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Ghoreschi, K., Balato, A., Enerbäck, C., & Sabat, R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00184-7 · Cited by 668
Trial of Spesolimab for Generalized Pustular Psoriasis
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Navarini, A. A., Zheng, M., Xu, J., Turki, H., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2111563 · Cited by 356
Self-citationInhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Turki, H., Hall, D. B., Shear, M., Baum, P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1811317 · Cited by 292
Self-citationClinical and genetic differences between pustular psoriasis subtypes
Twelves, S., Mostafa, A., Dand, N., Burri, E., Farkas, K., Wilson, R., Cooper, H. L., Irvine, A. D., Oon, H. H., Kingo, K., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.038 · Cited by 273
Self-citation
Metadata
- Authors
- Navarini, A. A., Burden, A. D., Capon, F., Mrowietz, U., Puig, L., Köks, S., Kingo, K., Smith, C., Barker, J. N., & the ERASPEN Network
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2017-08-29
- Volume
- 31
- Issue
- 11
- Pages
- 1792-1799
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2514982855
- Cited by
- 450
- References
- 17
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.